Population and evolutionary genetics of the PAH locus to uncover overdominance and adaptive mechanisms in phenylketonuria: Results from a multiethnic study.


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 30 11 2019
revised: 20 12 2019
accepted: 22 12 2019
pubmed: 11 1 2020
medline: 2 10 2020
entrez: 11 1 2020
Statut: ppublish

Résumé

Phenylketonuria (PKU) is the most common inborn error of amino acid metabolism in Europe. The reasons underlying the high prevalence of heterozygous carriers are not clearly understood. We aimed to look for pathogenic PAH variant enrichment according to geographical areas and patients' ethnicity using a multiethnic nationwide cohort of patients with PKU in France. We subsequently appraised the population differentiation, balancing selection and the molecular evolutionary history of the PAH locus. The French nationwide PKU study included patients who have been referred at the national level to the University Hospital of Nancy, and for whom a molecular diagnosis of phenylketonuria was made by Sanger sequencing. We performed enrichment analyses by comparing alternative allele frequencies using Fisher's exact test with Bonferroni adjustment. We estimated the amount of genetic differentiation among populations using Wright's fixation index (Fst). To estimate the molecular evolutionary history of the PAH gene, we performed phylogenetic and evolutionary analyses using whole-genome and exome-sequencing data from healthy individuals and non-PKU patients, respectively. Finally, we used exome-wide association study to decipher potential genetic loci associated with population divergence on PAH. The study included 696 patients and revealed 132 pathogenic PAH variants. Three geographical areas showed significant enrichment for a pathogenic PAH variant: North of France (p.Arg243Leu), North-West of France (p.Leu348Val), and Mediterranean coast (p.Ala403Val). One PAH variant (p.Glu280Gln) was significantly enriched among North-Africans (OR = 23·23; 95% CI: 9·75-55·38). PAH variants exhibiting a strong genetic differentiation were significantly enriched in the 'Biopterin_H' domain (OR = 6·45; 95% CI: 1·99-20·84), suggesting a balancing selection pressure on the biopterin function of PAH. Phylogenetic and timetree analyses were consistent with population differentiation events on European-, African-, and Asian-ancestry populations. The five PAH variants most strongly associated with a high selection pressure were phylogenetically close and were located within the biopterin domain coding region of PAH or in its vicinity. Among the non-PAH loci potentially associated with population divergence, two reached exome-wide significance: SSPO (SCO-spondin) and DBH (dopamine beta-hydroxylase), involved in neuroprotection and metabolic adaptation, respectively. Our data provide evidence on the combination of evolutionary and adaptive events in populations with distinct ancestries, which may explain the overdominance of some genetic variants on PAH. French National Institute of Health and Medical Research (INSERM) UMR_S 1256.

Sections du résumé

BACKGROUND BACKGROUND
Phenylketonuria (PKU) is the most common inborn error of amino acid metabolism in Europe. The reasons underlying the high prevalence of heterozygous carriers are not clearly understood. We aimed to look for pathogenic PAH variant enrichment according to geographical areas and patients' ethnicity using a multiethnic nationwide cohort of patients with PKU in France. We subsequently appraised the population differentiation, balancing selection and the molecular evolutionary history of the PAH locus.
METHODS METHODS
The French nationwide PKU study included patients who have been referred at the national level to the University Hospital of Nancy, and for whom a molecular diagnosis of phenylketonuria was made by Sanger sequencing. We performed enrichment analyses by comparing alternative allele frequencies using Fisher's exact test with Bonferroni adjustment. We estimated the amount of genetic differentiation among populations using Wright's fixation index (Fst). To estimate the molecular evolutionary history of the PAH gene, we performed phylogenetic and evolutionary analyses using whole-genome and exome-sequencing data from healthy individuals and non-PKU patients, respectively. Finally, we used exome-wide association study to decipher potential genetic loci associated with population divergence on PAH.
FINDINGS RESULTS
The study included 696 patients and revealed 132 pathogenic PAH variants. Three geographical areas showed significant enrichment for a pathogenic PAH variant: North of France (p.Arg243Leu), North-West of France (p.Leu348Val), and Mediterranean coast (p.Ala403Val). One PAH variant (p.Glu280Gln) was significantly enriched among North-Africans (OR = 23·23; 95% CI: 9·75-55·38). PAH variants exhibiting a strong genetic differentiation were significantly enriched in the 'Biopterin_H' domain (OR = 6·45; 95% CI: 1·99-20·84), suggesting a balancing selection pressure on the biopterin function of PAH. Phylogenetic and timetree analyses were consistent with population differentiation events on European-, African-, and Asian-ancestry populations. The five PAH variants most strongly associated with a high selection pressure were phylogenetically close and were located within the biopterin domain coding region of PAH or in its vicinity. Among the non-PAH loci potentially associated with population divergence, two reached exome-wide significance: SSPO (SCO-spondin) and DBH (dopamine beta-hydroxylase), involved in neuroprotection and metabolic adaptation, respectively.
INTERPRETATION CONCLUSIONS
Our data provide evidence on the combination of evolutionary and adaptive events in populations with distinct ancestries, which may explain the overdominance of some genetic variants on PAH.
FUNDING BACKGROUND
French National Institute of Health and Medical Research (INSERM) UMR_S 1256.

Identifiants

pubmed: 31923802
pii: S2352-3964(19)30838-2
doi: 10.1016/j.ebiom.2019.102623
pmc: PMC7000351
pii:
doi:

Substances chimiques

Phenylalanine Hydroxylase EC 1.14.16.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102623

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors who have taken part in this study declare that they do not have anything to disclose regarding conflicts of interest concerning this manuscript.

Références

Ir Med J. 1976 Sep 30;69(15):405-10
pubmed: 1010731
Genes Dis. 2015 Feb 25;2(3):247-254
pubmed: 30258868
J Med Genet. 1978 Jun;15(3):246-8
pubmed: 671494
Free Radic Biol Med. 2012 Apr 1;52(7):1123-34
pubmed: 22300645
Methods Mol Biol. 2010;628:341-72
pubmed: 20238091
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11479-84
pubmed: 11562485
Hum Mutat. 2007 Sep;28(9):831-45
pubmed: 17443661
Front Physiol. 2019 Aug 28;10:1116
pubmed: 31555147
J Med Genet. 1977 Feb;14(1):20-4
pubmed: 839495
Nucleic Acids Res. 2019 Jul 2;47(W1):W623-W631
pubmed: 31045209
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Am J Hum Genet. 2017 Nov 2;101(5):752-767
pubmed: 29100088
Am J Hum Genet. 1996 Jul;59(1):84-94
pubmed: 8659548
Mol Genet Metab. 2010;99 Suppl 1:S100-5
pubmed: 20123463
Eur J Hum Genet. 2015 Jun;23(6):831-6
pubmed: 25182131
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7485-90
pubmed: 27325755
Proc Natl Acad Sci U S A. 2007 May 15;104 Suppl 1:8655-60
pubmed: 17494744
JIMD Rep. 2018;42:71-77
pubmed: 29288420
PLoS One. 2018 Dec 6;13(12):e0207677
pubmed: 30521541
Nat Rev Genet. 2017 Oct;18(10):599-612
pubmed: 28804138
Orphanet J Rare Dis. 2015 Dec 15;10:158
pubmed: 26666653
J Inherit Metab Dis. 1986;9 Suppl 2:169-77
pubmed: 2877115
JIMD Rep. 2014;13:101-9
pubmed: 24190797
Genetics. 1964 Jan;49(1):49-67
pubmed: 17248194
Science. 2014 Feb 14;343(6172):747-751
pubmed: 24531965
PLoS Pathog. 2015 Mar 12;11(3):e1004667
pubmed: 25764397
Science. 2002 Jun 21;296(5576):2225-9
pubmed: 12029063
J Med Genet. 1978 Aug;15(4):317-9
pubmed: 568666
BMC Med. 2015 Jun 12;13:140
pubmed: 26071312
J Inherit Metab Dis. 2018 Nov;41(6):1159-1167
pubmed: 30159852
Nat Genet. 2013 Feb;45(2):197-201
pubmed: 23263489
PLoS One. 2014 Mar 25;9(3):e93179
pubmed: 24667843
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19333-8
pubmed: 23129628
PLoS Biol. 2012;10(9):e1001388
pubmed: 22984349
Nat Commun. 2018 Jan 4;9(1):67
pubmed: 29302025
Nat Rev Genet. 2014 Jun;15(6):379-93
pubmed: 24776769
Genet Med. 2016 Oct;18(10):1029-36
pubmed: 26890452
Nature. 2017 Jan 18;541(7637):302-310
pubmed: 28102248
Sci Rep. 2018 Jul 26;8(1):11251
pubmed: 30050108
FEBS Lett. 2004 Nov 19;577(3):507-11
pubmed: 15556637
JIMD Rep. 2017;34:19-26
pubmed: 27469133
Am J Hum Genet. 1998 Jul;63(1):71-9
pubmed: 9634518
Curr Protoc Hum Genet. 2017 Oct 18;95:1.22.1-1.22.23
pubmed: 29044472
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Am J Hum Genet. 1986 May;38(5):773-5
pubmed: 3717163
ACS Infect Dis. 2016 Nov 11;2(11):827-838
pubmed: 27641435
Hum Mutat. 2003 Apr;21(4):394-7
pubmed: 12655549
Am J Hum Genet. 2008 Jul;83(1):132-5; author reply 135-9
pubmed: 18606306
Ann Eugen. 1951 Mar;15(4):323-54
pubmed: 24540312
Orphanet J Rare Dis. 2017 Oct 12;12(1):162
pubmed: 29025426
J Neurochem. 2003 Aug;86(3):615-26
pubmed: 12859675
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
BMC Med Genet. 2017 Oct 5;18(1):108
pubmed: 28982351
Ann Hum Genet. 1975 May;38(4):461-9
pubmed: 1190737
Evolution. 1984 Nov;38(6):1358-1370
pubmed: 28563791
Am J Hum Genet. 1994 Aug;55(2):321-6
pubmed: 7913581
PLoS Genet. 2006 Apr;2(4):e64
pubmed: 16683038
Nature. 1967 Mar 4;213(5079):882-3
pubmed: 6030045
Theor Popul Biol. 2011 Feb-Mar;79(1-2):39-52
pubmed: 21094655
PLoS Genet. 2014 Aug 21;10(8):e1004561
pubmed: 25144706

Auteurs

Abderrahim Oussalah (A)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France; Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France. Electronic address: abderrahim.oussalah@univ-lorraine.fr.

Elise Jeannesson-Thivisol (E)

Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France.

Céline Chéry (C)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France; Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France.

Pascal Perrin (P)

Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France.

Pierre Rouyer (P)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France.

Thomas Josse (T)

Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France.

Aline Cano (A)

Centre of Reference for Inborn Metabolic Diseases, University Hospital La Timone, Marseille, France.

Magalie Barth (M)

Department of Genetics, University Hospital of Angers, Angers, France.

Alain Fouilhoux (A)

Metabolic Diseases Unit, Woman-Mother-Child Hospital, University Hospital of Lyon, Lyon, France.

Karine Mention (K)

Jeanne de Flandre Hospital, Lille, France.

François Labarthe (F)

Paediatric Unit, University Hospital of Tours, Tours, France.

Jean-Baptiste Arnoux (JB)

Reference Centre for Inherited Metabolic Diseases, Necker-Sick Children's Hospital, Imagine Institute, Paris Descartes University, Paris, France.

François Maillot (F)

Department of Internal Medicine, University Hospital of Tours, François Rabelais University, Tours, France.

Catherine Lenaerts (C)

Department of Paediatrics, University Hospital of Amiens, Amiens, France.

Cécile Dumesnil (C)

Paediatric Haematology and Oncology, University Hospital of Rouen, Rouen, France.

Kathy Wagner (K)

Department of Paediatrics, Lenval Hospital, Nice, France.

Daniel Terral (D)

Department of Paediatrics, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Pierre Broué (P)

Reference Centre for Inborn Errors of Metabolism, University Children Hospital, Toulouse, France.

Loic De Parscau (L)

Department of Paediatrics, University Hospital Morvan, Brest, France.

Claire Gay (C)

Department of Paediatrics, University Hospital of Saint-Etienne, Saint-Etienne, France.

Alice Kuster (A)

Paediatric Department, University Hospital of Nantes, Nantes, France.

Antoine Bédu (A)

Department of Neonatology, Mother and Child Hospital, Limoges, France.

Gérard Besson (G)

Department of Neurology, University Hospital of Grenoble, Grenoble, France.

Delphine Lamireau (D)

Department of Paediatrics, Pellegrin-Enfants Hospital, Bordeaux, France.

Sylvie Odent (S)

Department of Clinical Genetics, University Hospital of Rennes, Rennes, France.

Alice Masurel (A)

Department of Medical Genetics, Dijon Bourgogne University Hospital, Dijon, France.

Rosa-Maria Rodriguez-Guéant (RM)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France; Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France.

François Feillet (F)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France; Department of Paediatrics, University Hospital of Nancy, Nancy, France.

Jean-Louis Guéant (JL)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France; Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France. Electronic address: jean-louis.gueant@univ-lorraine.fr.

Fares Namour (F)

University of Lorraine, INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, Nancy, France; Department of Molecular Medicine, Division of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, Nancy, France; Reference Centre for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy F-54000, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH